Success and complication rate of miniscrew assisted non-surgical palatal expansion in adults - a consecutive study using a novel force-controlled polycyclic activation protocol.


Journal

Head & face medicine
ISSN: 1746-160X
Titre abrégé: Head Face Med
Pays: England
ID NLM: 101245792

Informations de publication

Date de publication:
11 Dec 2021
Historique:
received: 04 06 2021
accepted: 13 11 2021
entrez: 13 12 2021
pubmed: 14 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

Bone-borne miniscrew assisted palatal expansion (MAPE) is a common technique to improve maxillary transverse deficiency in young adolescents. Adult patients usually present a challenge, as they often require additional surgical assisted maxillary expansion (SARPE). There is still no clear statement about non-surgical expansion in adult patients using this technique. The aim of this study was to evaluate the success and complication rate of non-surgical palatal expansion in adults utilizing MAPE with a novel force-controlled polycyclic expansion protocol (FCPC). This consecutive study consisted of 33 adult patients with an average age of 29.1 ± 10.2 years (min. 18 years, max. 58 years), including one dropout patient. First, four miniscrews were inserted and after 12-weeks latency, the expander was placed and the FCPC protocol was applied (MAPE group). In case of missing expansion, a SARPE was performed (SARPE group). After maximum expansion, a cone beam CT was made and widening of the midpalatal suture was measured. The outcome variables were successful non-surgical expansion and, with sample size power above 80%, the odds of failed non-surgical expansion and associated complications were evaluated. The primary predictor variable was age. Statistical analysis was performed using R (Version 3.1) to calculate power, to construct various models for measuring the odds of requiring surgical intervention/complications, and others. Successful non-surgical expansion was achieved in 27 patients (84.4%), ranging from 18 to 49 years. Mean age differed significantly between both groups (26.8 ± 8.2 years vs. 41.3 ± 9.9 years; p < 0.001). Mean expansion at the anterior and posterior palate for the MAPE group was 5.4 ± 1.5 mm and 2.5 ± 1.1 mm, respectively. Among these subjects' complications were observed in 18.5%. Age significantly increased the odds of complications (p = 0.019). 1. The success rate of MAPE among individuals aged 18 to 49 years was 84.4%. 2. A V-shaped expansion pattern in the antero-posterior dimension was mostly observed. 3. Complications were significantly associated with age. 4. A careful expansion protocol seems to be beneficial to prevent unfavorable results in adult patients. Consecutive cohort study, Review Board No. EK-2-2014/0016.

Identifiants

pubmed: 34895287
doi: 10.1186/s13005-021-00301-2
pii: 10.1186/s13005-021-00301-2
pmc: PMC8665552
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50

Informations de copyright

© 2021. The Author(s).

Références

Angle Orthod. 2004 Oct;74(5):711-4
pubmed: 15529509
J Clin Orthod. 2013 Jun;47(6):375-81; quiz 388
pubmed: 23863561
Dental Press J Orthod. 2017 Feb;22(1):110-125
pubmed: 28444019
Am J Orthod Dentofacial Orthop. 2010 Jun;137(6):830-9
pubmed: 20685540
J Craniofac Surg. 2000 Sep;11(5):491-4
pubmed: 11314070
Angle Orthod. 2021 Mar 1;91(2):187-194
pubmed: 33351888
J Oral Maxillofac Surg. 2012 Oct;70(10):2394-402
pubmed: 22516838
Angle Orthod. 2015 Mar;85(2):253-62
pubmed: 25490552
Prog Orthod. 2017 Nov 1;18(1):34
pubmed: 29090368
Br J Oral Maxillofac Surg. 1999 Aug;37(4):268-72
pubmed: 10475647
Am J Orthod Dentofacial Orthop. 2016 May;149(5):716-28
pubmed: 27131254
Prog Orthod. 2014 Aug 29;15:52
pubmed: 25242527
Am J Orthod Dentofacial Orthop. 2013 Nov;144(5):759-69
pubmed: 24182592
Eur J Orthod. 2017 Feb;39(1):76-84
pubmed: 27036133
Am J Orthod Dentofacial Orthop. 2018 Jun;153(6):818-824
pubmed: 29853239
Am J Orthod Dentofacial Orthop. 2017 Jan;151(1):3-4
pubmed: 28024780
Angle Orthod. 2006 Jul;76(4):543-50
pubmed: 16808557
Int J Oral Maxillofac Surg. 2009 Apr;38(4):308-15
pubmed: 19278832
Angle Orthod. 2016 Sep;86(5):713-20
pubmed: 26938955
J Oral Maxillofac Surg. 2021 Jan;79(1):213-224
pubmed: 32422194
J Dent Res. 2002 Dec;81(12):810-6
pubmed: 12454093
J Oral Maxillofac Surg. 2011 Mar;69(3):899-905
pubmed: 21236540
Biology (Basel). 2021 Mar 03;10(3):
pubmed: 33802266
Eur J Orthod. 1998 Jun;20(3):255-61
pubmed: 9699403
Angle Orthod. 2019 Sep;89(5):713-720
pubmed: 30896250
Korean J Orthod. 2017 Mar;47(2):77-86
pubmed: 28337417
Am J Orthod Dentofacial Orthop. 2013 May;143(5):633-44
pubmed: 23631965
Cleft Palate Craniofac J. 2005 Mar;42(2):121-7
pubmed: 15748102
Bone. 2006 May;38(5):722-30
pubmed: 16413234
Am J Orthod. 1981 Jun;79(6):630-52
pubmed: 7015868
Korean J Orthod. 2019 Nov;49(6):360-371
pubmed: 31815104
Angle Orthod. 2018 Sep;88(5):649-664
pubmed: 29714067
Eur J Orthod. 2014 Oct;36(5):541-9
pubmed: 23221896
Angle Orthod. 2020 May 1;90(3):432-441
pubmed: 33378437

Auteurs

Heinz Winsauer (H)

Orthodontic Office, Belruptstrasse, Bregenz, Austria. heinz@dr-winsauer.at.

Andre Walter (A)

Department of Orthodontics, Universitat International de Catalunya (UIC), Barcelona, Spain.

Christos Katsaros (C)

Department of Orthodontics and Dentofacial Orthopedics, University of Bern, Bern, Switzerland.

Oliver Ploder (O)

Private Office for Oral and Maxillofacial Surgery, Facesurgery.at, Feldkirch, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH